🇺🇸 CANDICIDIN in United States

CANDICIDIN (CANDICIDIN) regulatory status in United States.

Marketing authorisations

FDA

  • Status: approved

FDA

  • Application: ANDA061613
  • Marketing authorisation holder: SANOFI AVENTIS US
  • Local brand name: VANOBID
  • Indication: TABLET — VAGINAL
  • Status: approved

Read official source →

FDA

  • Application: ANDA061596
  • Marketing authorisation holder: SANOFI AVENTIS US
  • Local brand name: VANOBID
  • Indication: OINTMENT — VAGINAL
  • Status: approved

Read official source →

CANDICIDIN in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Infectious Disease approved in United States

Frequently asked questions

Is CANDICIDIN approved in United States?

Yes. FDA has authorised it; FDA has authorised it; FDA has authorised it.

Who is the marketing authorisation holder for CANDICIDIN in United States?

Marketing authorisation holder not available in our data.